文献速递青光眼

前房内注射AAV-DJ.COMP-ANG1通过重塑小梁流出通路降低小鼠眼压

Intracameral Injection of AAV-DJ.COMP-ANG1 Reduces the IOP of Mice by Reshaping the Trabecular Outflow Pathway.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

研究比较不同血清型AAV眼前段转导效率,将编码COMP-ANG1或ZsGreen1的AAV-DJ注入野生型C57BL/6J小鼠前房,定期监测眼压和眼表,行眼灌注测流出易度,免疫染色观察Schlemm管及血管结构,透射电镜观察超微结构。结果显示AAV-DJ.COMP-ANG1降低小鼠眼压,无炎症或血管新生迹象,注射4周后常规流出易度和有效滤过面积显著增加,Schlemm管面积增大、巨液泡密度增加,内皮基底膜更不连续、邻小管组织更多孔。结论为前房内注射AAV-DJ.COMP-ANG1通过重塑小鼠眼小梁流出通路产生显著降眼压效果。

要点

  • AAV-DJ可有效感染小鼠眼前段。
  • 前房内注射AAV-DJ.COMP-ANG1降低野生型C57BL/6J小鼠眼压,未见炎症或血管新生迹象。
  • 注射4周后常规流出易度和有效滤过面积显著增加(P=0.005和P=0.04)。

核心结论

  • 前房内注射AAV-DJ.COMP-ANG1通过重塑小鼠眼小梁流出通路产生显著降眼压效果。

研究设计与样本

  • 研究比较不同血清型AAV在眼前段的转导特异性和效率,将编码COMP-ANG1或ZsGreen1(对照)的选定AAV注入野生型C57BL/6J小鼠前房,定期监测眼压和眼表,行眼灌注测量流出易度并标记小梁引流通路流型,免疫染色观察Schlemm管及角膜缘、视网膜和皮肤血管结构,透射电镜观察Schlemm管和小梁网超微结构改变。

主要发现

  • AAV-DJ可有效感染眼前段。
  • 前房内注射AAV-DJ.COMP-ANG1降低野生型C57BL/6J小鼠眼压,未见炎症或血管新生迹象。
  • AAV注射4周后,常规流出易度和有效滤过面积显著增加(P=0.005和P=0.04)。
  • COMP-ANG1组Schlemm管面积增大(P<0.001),内壁巨液泡密度增加(P=0.006)。
  • COMP-ANG1组Schlemm管内皮基底膜更不连续(P=0.046),邻小管组织更多孔(P=0.005)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The angiopoietin-1 (ANG1)-TIE signaling pathway orchestrates the development and maintenance of the Schlemm's canal (SC). In this study, we investigated the impact of adeno-associated virus (AAV)-mediated gene therapy with cartilage oligomeric matrix protein-ANG1 (COMP-ANG1) on trabecular outflow pathway. METHODS: Different serotypes of AAVs were compared for transduction specificity and efficiency in the anterior segment. The selected AAVs encoding COMP-ANG1 or ZsGreen1 (control) were delivered into the anterior chambers of wild-type C57BL/6J mice. The IOP and ocular surface were monitored regularly. Ocular perfusion was performed to measure the outflow facility and label flow patterns of the trabecular drainage pathway. Structural features of SC as well as limbal, retinal, and skin vessels were visualized by immunostaining. Ultrastructural changes in the SC and trabecular meshwork were observed under transmission electron microscopy. RESULTS: AAV-DJ could effectively infect the anterior segment. Intracameral injection of AAV-DJ.COMP-ANG1 lowered IOP in wild-type C57BL/6J mice. No signs of inflammation or angiogenesis were noticed. Four weeks after AAV injection, the conventional outflow facility and effective filtration area were increased significantly (P = 0.005 and P = 0.04, respectively). Consistently, the area of the SC was enlarged (P < 0.001) with increased density of giant vacuoles in the inner wall (P = 0.006). In addition, the SC endothelia lay on a more discontinuous basement membrane (P = 0.046) and a more porous juxtacanalicular tissue (P = 0.005) in the COMP-ANG1 group. CONCLUSIONS: Intracamerally injected AAV-DJ.COMP-ANG1 offers a significant IOP-lowering effect by remodeling the trabecular outflow pathway of mouse eyes.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Qiao Y, Sun Z, Tan C, et al. Intracameral Injection of AAV-DJ.COMP-ANG1 Reduces the IOP of Mice by Reshaping the Trabecular Outflow Pathway. Invest Ophthalmol Vis Sci. 2022. PMID: 36520455. doi:10.1167/iovs.63.13.15

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。